PLX stock news

Protalix Biotherapeutics, Inc. (NYSEMKT:PLX) Q1 2019 Earnings Conference Call May 06, 2019, 08:30 ET Company Participants Yossi Maimon - CFO, VP, Treasurer &amp Read more
Zacks Investment Research cut shares of Protalix Biotherapeutics (NYSEAMERICAN:PLX) from a buy rating to a hold rating in a research note released on Wednesday. According to Zacks, “Protalix is a bi Read more
Protalix Biotherapeutics Inc (NYSEAMERICAN:PLX) traded down 10.9% during trading on Monday . The company traded as low as $0.40 and last traded at $0.41. 1,976,434 shares traded hands during mid-day t Read more
Protalix Biotherapeutics (NYSEAMERICAN:PLX) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued on Tuesday. The brokerage currently has Read more
Among 3 analysts covering Polar Capital Holdings PLC (LON:POLR), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Polar Capital Holdings PLC had 10 analyst reports since October 4, 2 Read more
Plexure Group Ltd (PLX.NZ)’s closing price of $0.34 has closed above it’s Parabolic SAR reading, indicating a potential trend reversal. Parabolic SAR (or PSAR) is a simple, compact indicator that Read more
After a recent check, we have noted that Protalix Biotherapeutics (PLX) shares have dropped -8.75% lower over the past 4-weeks. Checking on performance over the last 5 trading days, shares have change Read more
Zooming in on shares of Plexure Group Ltd (PLX.NZ) we have seen that the stock price has gained 6.25% over the last 4-weeks. If we look back over the last half-year, we can see that the stock has move Read more
As we move closer towards the end of the year, investors may be undertaking a portfolio review. Reviewing trades over the past six months, investors should be able to see what has worked and what has Read more
Let’s check in on some recent stock price information on shares of Protalix Biotherapeutics (PLX). At the time of writing, shares had most recently hit 0.44. The stock opened at 0.43, and since the Read more
Analysts expect Point Loma Resources Ltd. (CVE:PLX) to report $-0.01 EPS on April, 25.After having $-0.02 EPS previously, Point Loma Resources Ltd.’s analysts see -50.00 % EPS growth. It closed at $ Read more
Checking in on the short-term signals on Protalix Biotherapeutics (PLX), we note that the current 7-day average directional indicator is Sell. This signal may be used to determine the market trend. Th Read more
Protalix Biotherapeutics (PLX) shares are under watch as the Aroon Oscillator is showing a negative trend building. The Aroon indicator, popularized by technician Tushar Chande, can be used to determi Read more

Proudly made at